The possible impact of uveitis in blindness: a literature survey.
暂无分享,去创建一个
[1] T. Dawber,et al. The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. , 1980, Survey of ophthalmology.
[2] Julian J. Nussbaum,et al. Long-term visual morbidity of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. , 1993, Ophthalmology.
[3] A. Rothova,et al. Causes and frequency of blindness in patients with intraocular inflammatory disease. , 1996, The British journal of ophthalmology.
[4] J. ten Doesschate. Causes of blindness in The Netherlands , 1982, Documenta ophthalmologica. Advances in ophthalmology.
[5] J. Thompson,et al. Recent trends in the registration of blindness and partial sight in Leicestershire. , 1989, The British journal of ophthalmology.
[6] Legal blindness among 10-year-old children in Metropolitan Atlanta: prevalence, 1985 to 1987. , 1992, American journal of public health.
[7] A. Haines,et al. Visual problems in the elderly population and implications for services. , 1992, BMJ.
[8] A. Sommer,et al. The prevalence of blindness and visual impairment among nursing home residents in Baltimore. , 1995, The New England journal of medicine.
[9] E. Perkins,et al. Uveitis in London and Iowa. , 1984, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.
[10] L. Hyman,et al. Epidemiology of eye disease in the elderly , 1987, Eye.
[11] B Thylefors,et al. A simplified methodology for the assessment of blindness and its main causes. , 1987, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.
[12] R. Klein,et al. Ten-year incidence of visual loss in a diabetic population. , 1994, Ophthalmology.
[13] O. Olurin. Etiology of blindness in Nigerian children. , 1970, American journal of ophthalmology.
[14] R. Olk,et al. Modified grid laser photocoagulation for diffuse diabetic macular edema. Long-term visual results. , 1991, Ophthalmology.
[15] R. Nussenblatt,et al. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. , 1987, American journal of ophthalmology.
[16] G S Baarsma,et al. The epidemiology and genetics of endogenous uveitis: a review. , 1992, Current eye research.
[17] J. Shields,et al. The clinical course of serpiginous choroidopathy. , 1979, American journal of ophthalmology.
[18] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[19] W. Wilson,et al. Ocular involvement in patients with onchocerciasis after repeated treatment with ivermectin. , 1990, American journal of ophthalmology.
[20] F L Ferris,et al. Photocoagulation for diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Research Group. , 1991, JAMA.
[21] W. Aclimandos,et al. Blindness in the City of Nottingham (1980-1985) , 1988, Eye.
[22] A D Négrel,et al. Global data on blindness. , 1995, Bulletin of the World Health Organization.
[23] W. Alemayehu,et al. Causes of blindness observed in the Eye Department of an Addis Ababa Hospital. , 1986, Ethiopian Medical Journal.
[24] P T de Jong,et al. Detection of intraocular antibody production to herpesviruses in acute retinal necrosis syndrome. , 1994, American journal of ophthalmology.
[25] P T de Jong,et al. Therapy of ocular toxoplasmosis. , 1993, International ophthalmology.
[26] A R Fielder,et al. Unrecognised and unregistered visual impairment. , 1994, The British journal of ophthalmology.
[27] A. Vitelli,et al. [Epidemiology of diabetic retinopathy]. , 1988, Minerva endocrinologica.
[28] E. Gregersen,et al. [Early photocoagulation of diabetic retinopathy]. , 1981, Ugeskrift for laeger.
[29] Y. Guex-Crosier,et al. Epidemiology of uveitis in Switzerland. , 1994, Ocular immunology and inflammation.
[30] G. Johnson,et al. Prevalence of Blindness and Eye Disease: Discussion Paper , 1989, Journal of the Royal Society of Medicine.
[31] D. Snydacker,et al. Blindness and visual impairment in an American urban population. , 1990, Archives of ophthalmology.
[32] A. Rothova,et al. Uveitis and systemic disease. , 1992, The British journal of ophthalmology.
[33] R. Klein,et al. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. , 1992, Ophthalmology.
[34] Joanne Katz,et al. Blindness and Visual Impairment in an American Urban Population-Reply , 1990 .
[35] V. Klauss,et al. [Cause of blindness in Bavaria. Evaluation of a representative sample from blindness compensation records of Upper Bavaria]. , 1992, Klinische Monatsblatter fur Augenheilkunde.
[36] J. Javitt. Universal coverage and preventable blindness. , 1994, Archives of ophthalmology.
[37] K. Waddell,et al. Is leprosy blindness avoidable? The effect of disease type, duration, and treatment on eye damage from leprosy in Uganda. , 1995, The British journal of ophthalmology.
[38] A. Foster. Who will operate on Africa's 3 million curably blind people? , 1991, The Lancet.
[39] J C Javitt,et al. Preventing blindness in Americans: the need for eye health education. , 1995, Survey of ophthalmology.
[40] S. Lightman,et al. Visual prognosis in Behçet's disease. , 1993, Ocular immunology and inflammation.
[41] C. Meenken,et al. Outcomes of HLA-B27-positive and HLA-B27-negative acute anterior uveitis. , 1995, American journal of ophthalmology.
[42] Laurie J. Bassi,et al. Federal budgetary costs of blindness. , 1992, The Milbank quarterly.
[43] A Rothova,et al. Ocular involvement in toxoplasmosis. , 1993, The British journal of ophthalmology.
[44] W. Wilson,et al. SIDE-EFFECTS OF IVERMECTIN IN TREATMENT OF ONCHOCERCIASIS , 1989, The Lancet.
[45] N. Bressler,et al. The grading and prevalence of macular degeneration in Chesapeake Bay watermen. , 1989, Archives of ophthalmology.
[46] T. Rosenberg,et al. Incidence of registered visual impairment in the Nordic child population. , 1996, The British journal of ophthalmology.
[47] A. R. Potter. Preventing blindness worldwide , 1994, BMJ.
[48] A. R. Potter. Causes of blindness and visual handicap in the Central African Republic. , 1991, The British journal of ophthalmology.
[49] Johannes R. Vingerling,et al. The prevalence of age-related maculopathy in the Rotterdam Study. , 1995, Ophthalmology.
[50] A. Foster,et al. Blindness in the developing world. , 1993, The British journal of ophthalmology.
[51] M. O'Keefe,et al. Childhood blindness in the Republic of Ireland: a national survey. , 1991, The British journal of ophthalmology.
[52] J Katz,et al. Blindness and visual impairment in an American urban population. The Baltimore Eye Survey. , 1990, Archives of ophthalmology.
[53] G. Baarsma,et al. Epidemiology of uveitis. , 1995, Current opinion in ophthalmology.
[54] R. Wormald,et al. Registration of blind and partially sighted people. , 1994, The British journal of ophthalmology.
[55] S. Cousens,et al. Distribution and aetiology of blindness and visual impairment in mesoendemic onchocercal communities, Kaduna State, Nigeria. Kaduna Collaboration for Research on Onchocerciasis. , 1994, The British journal of ophthalmology.
[56] C. Gilbert,et al. Visual loss in an onchocerciasis endemic community in Sierra Leone. , 1993, The British journal of ophthalmology.
[57] A. Rothova,et al. Blindness from uveitis in a hospital population in Sierra Leone. , 1994, The British journal of ophthalmology.
[58] R. Miettinen. INCIDENCE OF UVEITIS IN NORTHERN FINLAND , 1977, Acta ophthalmologica.